10.1056/NEJM199807233390404
NAEs were identified using SOC = nervous system disorders (SOC ID: 10,029,205) and primary SOC = Yes, encompassing 1075 PTs from MedDRA version 27.0
Retatrutide significantly reduced body weight (mean difference [MD]: 14.33%), body mass index (MD: 5.38), waist circumference (MD: 10.51 cm), fasting plasma glucose (MD: 23.51 mg/dL), hemoglobin A1c (MD: 0.91%), and systolic and diastolic blood pressure (MD: 9.88 mm Hg and 3.88 mm Hg, respectively), all with P values 35 kg/m 2 , frequently resulting in diabetes remission and improvement in associated obesity-related conditions
Once approved by the FDA, it will likely follow a gradual dose step-up schedule, with dose increases every 4 weeks similar to other weight-loss injections
Sources NIDDK Prescription Medications to Treat Overweight and Obesity Wegovy Prescribing Information FDA Semaglutide Injection MedlinePlus Dr
Hello Alpha does not discriminate and makes a point of welcoming individuals of all genders to its telehealth platform